Papillary renal cell carcinoma with prominent spindle cell stroma - tumor mimicking mixed epithelial and stromal tumor of the kidney: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 6 cases.


Journal

Annals of diagnostic pathology
ISSN: 1532-8198
Titre abrégé: Ann Diagn Pathol
Pays: United States
ID NLM: 9800503

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 30 09 2019
accepted: 23 10 2019
pubmed: 22 12 2019
medline: 27 10 2020
entrez: 22 12 2019
Statut: ppublish

Résumé

Papillary renal cell carcinoma (PRCC) is currently a well-studied type of RCC. In addition to PRCC type 1, there are a number of other subtypes and variants of PRCCs which have been reported. We describe a series of 6 PRCCs with papillary, micropapillary and/or tubulopapillary architecture and prominent spindle cell stroma, resembling stroma in mixed epithelial and stromal tumor of the kidney (MESTK) or sarcomatoid RCC. Clinicopathologic, morphologic, immunohistochemical and molecular features were analyzed. All patients were males with an age range of 44-98 years (mean 65.3, median 65.5 years). Tumor size ranged from 2.4-11.4 cm (mean 5.8, median 4.5 cm). Follow-up data were available for 4 patients, ranging from 3 to 96 months (mean 42.75, median 36 months). Epithelial cells were mostly cylindrical with eosinophilic cytoplasm, showing nuclear grade 2 and 3 (ISUP/WHO). In all cases, loose to compact prominent stroma composed of spindle cells, without malignant mesenchymal heterologous elements was detected. No atypical mitoses were found, while typical mitoses were rare in both epithelial and stromal components. Epithelial cells were positive for CK7, AMACR, and vimentin in all cases, while negative for TFE3, HMB45, desmin, CD34, and actin. The stroma was positive for vimentin, actin and focally for CD34, while negative for CK7, AMACR, TFE3, HMB45, and desmin. Estrogen and progesterone receptors were completely negative. FH and SDHB expression was retained in all analyzable cases. Proliferative index was barely detectable in stromal component and low in epithelial component, ranging 0 to 5% positive stained cells/high power field. Copy number variation was variable with no distinct pattern. No mutations in CDKN2A, BAP1, MET were detected. PRCC with MESTK-like features is a distinct variant of PRCC mimicking MESTK. Our findings add to the body of literature on ever expanding variants of PRCCs. Both epithelial and stromal components lacked true Müllerian features, which was also proven by immunohistochemistry.

Identifiants

pubmed: 31862520
pii: S1092-9134(19)30370-3
doi: 10.1016/j.anndiagpath.2019.151441
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

151441

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest All authors declare no conflict of interest.

Auteurs

Joanna Rogala (J)

Department of Pathology, Charles University, Medical Faculty and Charles University Hospital Plzen, Czech Republic; Department of Pathology, Regional Specialist Hospital Wroclaw, Poland.

Fumiyoshi Kojima (F)

Department of Human Pathology, Wakayama Medical University, Wakayama, Japan.

Reza Alaghehbandan (R)

Department of Pathology, Faculty of Medicine, University of British Columbia, Royal Columbian Hospital, Vancouver, BC, Canada.

Abbas Agaimy (A)

Department of Pathology, University of Erlangen, Erlangen, Germany.

Petr Martinek (P)

Department of Pathology, Charles University, Medical Faculty and Charles University Hospital Plzen, Czech Republic.

Ondrej Ondic (O)

Department of Pathology, Charles University, Medical Faculty and Charles University Hospital Plzen, Czech Republic.

Monika Ulamec (M)

"Ljudevit Jurak" Pathology Department, Clinical Hospital Center "Sestre milosrdnice", Pathology Department, Medical University, Medical Faculty Zagreb, Croatia.

Maris Sperga (M)

Department of Pathology, Riga Stradin's University, Riga, Latvia.

Kvetoslava Michalova (K)

Department of Pathology, Charles University, Medical Faculty and Charles University Hospital Plzen, Czech Republic.

Kristyna Pivovarcikova (K)

Department of Pathology, Charles University, Medical Faculty and Charles University Hospital Plzen, Czech Republic.

Tomáš Pitra (T)

Department of Urology, Charles University, Medical Faculty and Charles University Hospital Plzen, Czech Republic.

Milan Hora (M)

Department of Urology, Charles University, Medical Faculty and Charles University Hospital Plzen, Czech Republic.

Ivan Ferak (I)

Department of Pathology, Agel Laboratory, Novy Jicin, Czech Republic.

Jana Marečková (J)

Department of Pathology, Charles University, Medical Faculty and Charles University Hospital Plzen, Czech Republic.

Michal Michal (M)

Department of Pathology, Charles University, Medical Faculty and Charles University Hospital Plzen, Czech Republic.

Ondrej Hes (O)

Department of Pathology, Charles University, Medical Faculty and Charles University Hospital Plzen, Czech Republic. Electronic address: hes@medima.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH